These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4435958)

  • 21. Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
    Reichert E; Mauler R
    Dev Biol Stand; 1975; 28():319-23. PubMed ID: 1126575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative trial of influenza vaccines. II. Adverse reactions in children and adults.
    Barry DW; Mayner RE; Hochstein HD; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Sullivan JL; Gerety RJ
    Am J Epidemiol; 1976 Jul; 104(1):47-59. PubMed ID: 132867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study.
    Jennings R; Smith T; Potter CW
    Med Microbiol Immunol; 1981; 169(4):247-58. PubMed ID: 6268957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and quantitation of the components of polyvalent inactivated influenza virus vaccines by immunodiffusion.
    Myers MG; Tauraso NM
    Appl Microbiol; 1972 May; 23(5):946-50. PubMed ID: 4624212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
    Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
    Johansson BE
    Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.
    Nicholson KG; Colegate AE; Podda A; Stephenson I; Wood J; Ypma E; Zambon MC
    Lancet; 2001 Jun; 357(9272):1937-43. PubMed ID: 11425416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.
    Kim KH; Lee YT; Park S; Jung YJ; Lee Y; Ko EJ; Kim YJ; Li X; Kang SM
    Virology; 2019 Sep; 535():179-188. PubMed ID: 31310875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains.
    Anker WJ; Bakker AK; Masurel N
    Infect Immun; 1978 Jul; 21(1):96-101. PubMed ID: 711325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans.
    Webster RG; Kasel JA; Couch RB; Laver WG
    J Infect Dis; 1976 Jul; 134(1):48-58. PubMed ID: 59787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.
    Petrie JG; Ohmit SE; Truscon R; Johnson E; Braun TM; Levine MZ; Eichelberger MC; Monto AS
    J Infect Dis; 2016 Oct; 214(8):1142-9. PubMed ID: 27095420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response of hamsters to A2-Hong Kong virus vaccine after priming by heterotypic virus infection.
    Potter CW; Jennings R; Rees RC; McLaren C
    Infect Immun; 1973 Aug; 8(2):137-44. PubMed ID: 4725696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new influenza subunit vaccine: reactogenicity and antigenicity in comparison to split and whole virus vaccines (author's transl)].
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz A; SchmidtG
    Infection; 1976; 4(2):73-9. PubMed ID: 947849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.
    Quinnan GV; Schooley R; Dolin R; Ennis FA; Gross P; Gwaltney JM
    Rev Infect Dis; 1983; 5(4):748-57. PubMed ID: 6622889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.